ARCHIVES

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

On Biomedical Malthusianism; Varmus, et al. Propose a Strategy For Saving Biomedical Research

May 2, 2014

Tobacco Industry Walkout Unlikely To Imperil Legislation

April 17, 1998

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995